DARE (Dare Bioscience, Inc. Common Stock) Stock Analysis - Politician Trades

Dare Bioscience, Inc. Common Stock (DARE) is a publicly traded Healthcare sector company. As of May 21, 2026, DARE trades at $2.36 with a market cap of $31.61M and a P/E ratio of -2.46. DARE moved +5.11% today. Year to date, DARE is +17.09%; over the trailing twelve months it is -19.38%. Its 52-week range spans $1.27 to $9.19. Analyst consensus is buy with an average price target of $10.00. Rallies surfaces DARE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded DARE stock?

Rallies tracks politician and congressional stock disclosures for DARE, including purchases, sales, transaction dates, owners, and reported trade amounts when available.

DARE Key Metrics

Key financial metrics for DARE
MetricValue
Price$2.36
Market Cap$31.61M
P/E Ratio-2.46
EPS$-0.96
Dividend Yield0.00%
52-Week High$9.19
52-Week Low$1.27
Volume338
Avg Volume0
Revenue (TTM)$1.16M
Net Income$-12.02M
Gross Margin0.00%

Latest DARE News

DARE Analyst Consensus

2 analysts cover DARE: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $10.00.

Common questions about DARE

Which politicians traded DARE stock?
Rallies tracks politician and congressional stock disclosures for DARE, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in DARE?
Yes. Rallies tracks politician and congressional stock disclosures for DARE, including reported purchases, sales, dates, owners, and trade amounts when available.
Is DARE research on Rallies investment advice?
No. Rallies provides research, data, and educational context for DARE. It does not provide personalized investment advice.
DARE

DARE